tiprankstipranks
Trending News
More News >
Med Biogene (TSE:MBI.H)
:MBI.H
Canadian Market

Med Biogene (MBI.H) Financial Statements

Compare
4 Followers

Med Biogene Financial Overview

Med Biogene's market cap is currently C$258.87K. The company's EPS TTM is C$-0.001; its P/E ratio is ―; Med Biogene is scheduled to report earnings on May 30, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit-----
Operating Income$ -58.11K$ -63.06K$ -59.96K$ -54.54K$ -63.48K
EBITDA$ -58.11K$ -63.06K$ -59.96K$ -54.54K$ -63.48K
Net Income$ -58.11K$ -63.06K$ -59.96K$ -54.54K$ -63.48K
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 2.31K$ 3.00K$ 10.79K$ 81.83K$ 13.15K
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -713.00$ -407.00$ -9.19K$ -79.24K$ -10.96K
Total Liabilities$ 129.30K$ 69.23K$ 92.01K$ 178.16K$ 50.42K
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow
Operating Cash Flow$ 2.94K$ -8.32K$ -145.12K$ 72.80K$ -151.46K
Investing Cash Flow
Financing Cash Flow
Currency in USD

Med Biogene Earnings and Revenue History

Med Biogene Debt to Assets

Med Biogene Cash Flow

Med Biogene Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis